advertisement

10 Things to Know for Thursday

Your daily look at late-breaking news, upcoming events and the stories that will be talked about Thursday:

1. NEW TURMOIL SWIRLS AROUND TRUMP

The president emphatically rejects claims that he was disrespectful to the grieving family of a slain soldier.

2. WHY WALL STREET IS CHEERING

The Dow, led by technology companies and banks, closes above 23,000 for the first time.

3. OBAMA RETURNING TO POLITICAL SPOTLIGHT

The ex-president will publicly stump for Democratic gubernatorial candidates in Virginia and New Jersey.

4. US REGULATORS OK NEW GENE THERAPY

The treatment targets aggressive lymphoma in adults and involves removing cells from a patient and reprogramming them.

5. LAWMAKERS SEE MOVEMENT ON HEALTH CARE

The authors of a bipartisan plan to calm health insurance markets say they'll push the proposal forward.

6. SUSPECT IN WORKPLACE SHOOTING CAPTURED

A gunman shoots five of his co-workers at a Maryland office park, killing three of them before fleeing. Hours later, a suspect is taken into custody.

7. WHAT'S A FIRST FOR SAUDI ARABIA

The kingdom - trying to portray itself as ready to join the ranks of modern, tolerant societies - names a spokeswoman - rather than a man - for its U.S. embassy.

8. BRAIN CANCER CLAIMS ROCKER AT 53

Gord Downie made himself part of Canada's national identity with songs about hockey and small towns as lead singer and songwriter of The Tragically Hip.

9. HOW PLANTS USE TRICK OF PHYSICS

Scientists say some flowers, helped by sunshine, produce a blue halo, apparently to catch the attention of foraging bees.

10. DOPING ALLEGED AT IDITAROD

For the first time ever at the world's most famous sled dog race, several dogs test positive for a prohibited drug.

FILE - In this May 2016 file photo provided by Kite Pharma, cell therapy specialists at the company's manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in the lab to fight cancer. On Wednesday, Oct. 18, 2017, the Food and Drug Administration approved sales of the therapy Yescarta, developed by Kite Pharma. It is the second gene therapy for U.S. patients _ the first one for adults _ a custom-made, one-time treatment for certain common types of the blood cancer lymphoma. (Kite Pharma via AP, File) The Associated Press
This 2015 photo provided by Edwige Moyroud shows a Hibiscus trionum flower. The region at the base of the petals contains a dark pigment but appears blue at certain angles due to an optical effect on the surface of the cells. The color makes flowers more visible to the bees. (Edwige Moyroud via AP) The Associated Press
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.